![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Direxion Daily Financial Bull 3X Shares ETF
FAS
Spdr S&P Bank Etf
KBE
Ultra Financials Proshares
UYG
4
SPDR S&P Metals & Mining ETF
XME
5
SPDR S&P Retail ETF
XRT
US Stock MarketDetailed Quotes
Cognition Therapeutics (CGTX)
- 1.460
- -0.060-3.95%
Close Dec 17 16:00 ET
128.88MMarket Cap-3.11P/E (TTM)
1.590High1.460Low801.94KVolume1.530Open1.520Prev Close1.22MTurnover0.98%Turnover RatioLossP/E (Static)88.27MShares3.83052wk High3.53P/B119.38MFloat Cap0.22252wk Low--Dividend TTM81.77MShs Float13.800Historical High--Div Yield TTM8.55%Range %0.222Historical Low1.520Avg Price1Lot Size
CGTX Stock Chart
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
CGTX Orderflow
Unit: --
CGTX Orderflow Trend
IntradayDayWeekMonth
No Data
Cognition Therapeutics (CGTX) News
Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely?
Cognition Therapeutics Says Zervimesine Expanded Access Program Reaches Full Enrollment
Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies | DelveInsight
Express News | Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (Ct1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (Ctad) Conference
B. Riley Securities Reiterates Buy on Cognition Therapeutics, Raises Price Target to $3
B. Riley Securities Initiates Cognition Therapeutics(CGTX.US) With Buy Rating, Announces Target Price $3
Cognition Therapeutics (CGTX) Stock Forum
$Cognition Therapeutics (CGTX.US)$ stage 3 trial report not yet announced?
$Cognition Therapeutics (CGTX.US)$ what do we think is happening with this stock? I’ve been holding it since start of September.
1
2
$Cognition Therapeutics (CGTX.US)$ “we expect FDA will have a decision on breakthrough designation for zervimesine in DLB in the third quarter 2025”. “We expect these milestones will be valuable to potential partners as we continue to evaluate our options to support development of zervimesine.”
7
10
$Cognition Therapeutics (CGTX.US)$ any chance it will move up soon ?
6
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)